trelarosa, — 
Articles by
Recent Posts
- FDA questions NurOwn’s efficacy, quality ahead of today’s hearing
- ALS affects my hand strength, but it’s no match for my determination
- Canadian initiative to advance AI tech to better diagnose ALS
- Dosing of healthy adults begins in Phase 1 study of oral CVN293
- Early 2024 eyed for approval decision in EU on masitinib for ALS